جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

مقالمفتوح (مستودع)2024

Are drug safety measures harmonized? A real-world evidence from three regulatory authorities

Saudi Pharmaceutical Journal · مجلد 32 (3) · 101963-101963

Background: Risk minimization measures (RMMs) are interventions intended to mitigate or prevent the occurrence of adverse reactions associated with medications. Having consistent measures across regulatory bodies (i.e., the Saudi Food and Drug Authority (SFDA), the United States Food and Drug Administration (US FDA), and the European Medicines Agency (EMA)) benefits medication use and safety and ultimately the patient. Objectives: This study aimed to investigate whether there is variability in these published RMMs between the three regulatory bodies. Methods: A specific data collection form was created to extract information from the SFDA's RMM list, US FDA's Risk Evaluation and Mitigation Strategy (REMS) list, and EMA's Risk Management Plan (RMP) list, as of February 2022 all RMMs that were available on the websites were reviewed. Medications with the same trade name were matched across regulators, and unmatched medications were checked for approval status. For medication groups such as NSAIDs in the SFDA's RMM list, they were matched by searching for the groups individually in the regulatory websites. All risks and types of minimizing measures were compared. Results: A total of 317 medications were retrieved from the SFDA's RMM list. The majority of medication classes were immunosuppressants (n = 60), antihypertensive (n = 33), and oncology medication (n = 29). There were only 62 medications with REMS from the US FDA website, a total of 14 medications were approved by the SFDA, and only nine medications were matched with the SFDA's RMM list. Also, there were 828 medications with RMP from the EMA website, a total of 334 has RMM, 128 are approved by the SFDA, and 71 matched with the SFDA's RMM list. Furthermore, seven medications were matched between SFDA, US FDA and EMA. After content review, four medications had similar risks and measures across the regulators and three medications had different risks and measures across the regulators. For the medication groups, a total of 36 groups were in the SFDA's list, 18 groups were matched with the US FDA, and 14 were matched with the EMA. Conclusions: Our study showed substantial differences among the regulatory authorities regarding RMMs. Harmony in published risk measures can have a significant impact on medication safety.

risk minimization measuresdrug safetyregulatory harmonizationrisk evaluation and mitigation strategy
مقالوصول مفتوح2024

Giant Unruptured Internal Carotid Artery Aneurysm

Cureus · مجلد 16 (1) · r116-r116

[This retracts the article DOI: 10.7759/cureus.20423.].

internal carotid artery aneurysmgiant aneurysmunruptured aneurysmcarotid artery
مقالمفتوح (مستودع)2024

Potential Anti-Diabetic Benefits of Momordica charantia Extracts on Experimental Diabetes and its Complications

International Journal of Pharmacology · مجلد 20 (1) · 81-91

Background and Objective: The Momordica charantia L. (Cucurbitaceae) plant is a natural medicine that is commonly used in the treatment of a wide range of ailments, including diabetes. The current study validates two common types of extracts (methanolic and water) of Momordica charantia (MC) for antidiabetic effects and compares their efficacy in preventing experimental diabetic complications. Materials and Methods: The rats with a fasting serum glucose level above 200 mg dL–1 at 96 hrs after streptozotocin (STZ) injection were considered diabetic and included in the study. They were administered with any of the three doses (45, 90 or 180 mg kg–1) of methanolic or aqueous extracts of MC based on their respective experimental groups. After 14 and 28 days, parameters such as body weight, serum glucose, lipid profile, hemoglobin content and antioxidant status were recorded. The observations were statistically examined using a One-way ANOVA and p<0.05 indicated significance. Results: According to the research findings, rats with STZ-induced diabetes had a significant (p<0.05) variance in their body weight (177±5.64), serum glucose levels (216.4±3.96), lipid profiles [cholesterol (107.38±3.70), triglycerides (168.68±14.70)], hemoglobin levels (7.5±0.14) and antioxidant status. These effects were found to become more prominent after 14 days of exposure. By providing either methanolic or water extracts of MC at different doses, the STZ-induced alterations in body weight and hyperglycemia were significantly (p<0.05) reversed. Besides, the extracts attenuated the hyperlipidemic, depleted antioxidant stress and improved hemoglobin levels in diabetic rats up to 28 days. Comparing the two extracts, the methanolic extract has shown greater efficacy than the water extract and the effects matches with that of glibenclamide. Conclusion: The findings of the current investigation verify the anti-diabetic potential of the MC and show its ability to serve as an alternate therapy for managing hyperglycemia-induced complications. Besides, attenuation in oxidative stress, diminished hemoglobin level, weight loss and hyperlipidemia, both extracts might benefit diabetic conditions by minimizing the complications related to hyperglycemia.

Momordica charantiabitter melon extractantidiabetic activityexperimental diabetes
مقالوصول مفتوح2024

Exploring an E-Health Cloud Computing Adoption in Saudi Arabia: Review Article

International Journal of Intelligent Systems and Applications in Engineering

Within the ever-changing landscape of health care reform, notably in Saudi Arabia, the combination of e-health and cloud computing has the potential to be a game-changer. The use of cloud computing in electronic health care is expertly navigated within the context of the Saudi Arabian setting by means of this comprehensive assessment research. The objective of this study is to investigate the implementation of an e-health cloud computing system in Saudi Arabia by utilizing literature review from various online data repositories. The purpose of this investigation is to identify the factors that have an impact on cloud computing in the healthcare industry. To establish a solid foundation for policy-makers and stakeholders to leverage in their decision-making processes and to ensure the successful adoption of cloud computing technology in Saudi Arabia, researchers in this study proposed an adoption framework by integrating all of the factors revealed from content analysis, the theoretical background, and the existing framework for technology adoption. All of these factors were incorporated into the framework. In order to understand how the implementation of e-health cloud computing within Saudi Arabia's health care system may be properly optimized, and if additional research and analysis are required.

e-healthcloud computingtechnology adoptionadoption framework
مقالوصول مفتوح2024

Olecranon stress fracture in a gymnastics player: Insight into an early detection and integrated care approach: Case report

Radiology Case Reports · مجلد 19 (3) · 1228-1231

We describe a case report of a 13 year-old a gymnastic athlete who was diagnosed with an olecranon stress fracture associated with mild medial epicondyle apophysitis, Following a brief review of the literature on this case, the researchers call attention to the significance of and imaging assessment especially MR in determining the correct diagnosis and identifying concomitant injuries. MRI findings concluded firstly a marked bone marrow edema seen at the posterior medial aspect of the olecranon with linear low signal traversing the olecranon related to a stress fracture. Secondly, subchondral linear low signal and bone marrow edema at the radial head related to another stress fracture/reaction injury. Thirdly, bone marrow edema at the medial apophysis with overlying soft tissue edema suggestive for medial epicondylitis.

youth athletesbone marrow edemamedial epicondylitisMRI diagnosis